News
News
- Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE
06/21/2018 / 08:01 - GlobeNewswire - Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE
06/21/2018 / 08:00 - GlobeNewswire - BioCryst Announces Presentation of Additional Analyses of the APeX-1 Clinical Trial of BCX7353 at the 2018 European Academy of Allergy and Clinical Immunology (EAACI) Congress
05/29/2018 / 14:00 - GlobeNewswire - Horizon Discovery Group plc: Revenue Multiple Represented by the Value of Abcam's Unsolicited Proposal
05/08/2018 / 12:01 - GlobeNewswire - Outsourcing in Drug Discovery 2017-2018 & 2022 - Focus on the Contract Research Organization (CRO) Market
05/03/2018 / 13:30 - GlobeNewswire - Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging 2017-2022 - Market to Reach $197 Billion by 2022, from $136 Billion in 2017
04/10/2018 / 10:36 - GlobeNewswire - Global Endometriosis Business Report 2018: Overview, Treatment, Innovations & Approvals, Recent Industry Activity & Focus on Select Players
03/22/2018 / 16:50 - GlobeNewswire - Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform
03/08/2018 / 07:48 - GlobeNewswire - Evotec and Sanofi in exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform
03/08/2018 / 07:46 - GlobeNewswire - New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for HAE to be Presented at 2018 AAAAI/WAO Joint Congress
03/03/2018 / 15:46 - GlobeNewswire
Real-time